GoodRx says approved peptides went through safety and effectiveness testing, while wellness peptides sold without approval lack that evidence and carry risks.
Recap by typeshit. Full story at St. Louis Post-Dispatch.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
An older explainer sorting the weight loss market into approved medications, telehealth compounded drugs, online gray market peptides and supplements.
The two drugs brought in $14.9 billion of Lilly's $23.0 billion fiscal Q2 revenue while US prices fell 9%, Trefis says. The Q3 report is expected around October 29.
A post hoc look at phase 3 ICONIC data found similar efficacy, safety and drug levels in 31 GLP-1 users. The researchers note the small sample limits the conclusions.
Loading…